Drug-resistant tuberculosis: A disease of target populations in Houston, Texas

Journal of Infection

Volumn 53, Issue 1, 2006, Pages 5-11

  El Sahly, Hana M ^a   Teeter, Larry D ^a   Pawlak, Rebecca R ^a   Musser, James M ^a   Graviss, Edward A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

HIV; Molecular epidemiology; Pleural effusion; Resistant tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PLEURA EFFUSION; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; THORAX RADIOGRAPHY; UNITED STATES;

ANTITUBERCULAR AGENTS; CASE-CONTROL STUDIES; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; TEXAS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 33745482888     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2005.10.002     Document Type: Article

References (39)

1. Crofton J., and Mitchison D.A. Streptomycin resistance in pulmonary tuberculosis. Br Med J 2 (1948) 1009-1015
2. Goble M., Iseman M.D., Madsen L.A., and Waite D. Ackerson L, Horsburgh CR Jr. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 328 (1993) 527-532
3. Geerligs W.A., Van Altena R., and De Lange W.C.M. Van Soolingen D, van Der Werf TS. Multidrug-resistant tuberculosis: long-term treatment outcomes in The Netherlands. Int J Tuberc Lung Dis 4 (2000) 758-764
4. Moore-Gillon J. Multidrug-resistant tuberculosis: this is the cost. Ann NY Acad Sci 953 (2001) 233-240
5. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America. Treatment of tuberculosis. Am J Respir Crit Care Med 167 (2003) 603-662
6. Park M.M., Davis A.L., and Schluger N.W. Cohen H, Rom WN. Outcome of MDR-TB patients, 1983-1993: prolonged survival with appropriate therapy. Am J Respir Crit Care Med 153 (1996) 317-324
7. Espinal M.A., Kim S.J., and Suarez P.G. Kam KM, Khomenko AG, Migliori GB, et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 283 (2000) 2537-2545
8. Lan N.T.N., Lademarco M.F., Binkin N.J., Tung L.B., Quy H.T., and Cj N.V. A case series: initial outcome of persons with multidrug-resistant tuberculosis after treatment with the WHO standard retreatment regimen in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 5 (2001) 575-578
9. World Health Organization. Anti-tuberculosis drug resistance in the world: prevalence and trends. Report No. 2. WHO/CDS/TB/2000.278 (2000), WHO, Geneva
10. Centers for Disease Control and Prevention. Reported tuberculosis in the United States (2003). http://www.cdc.gov/nchstp/tb/surv/surv2003 [available at www.cdc.gov/nchstp/tb/surv/surv2003]
11. Centers for Disease Control and Prevention. Tuberculosis morbidity among United States-born and foreign-born populations-United States, 2000. Morb Mortal Wkly Rep 5 (2002) 101-104
12. El Sahly H.M., Adams G.J., Soini H.,. Teeter L, Musser JM, Graviss EA. Epidemiologic differences between United States- and foreign-born tuberculosis patients in Houston, Texas. J Infect Dis 183 (2001) 461-468
13. Talbot E.A., Moore M., McRay E., and Binkin N.J. Tuberculosis among foreign-born persons in the United States, 1993-1998. JAMA 284 (2000) 2894-2900
14. Espinal M.A., Laserson K., Camacho M.,. Fusheng Z, Kim SJ, Tlali RE, et al. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis 5 (2001) 887-893
15. Gordin F.M., Nelson E.T., and Matts J.P. Cohn DL, Ernst J, Benator D, et al. The impact of human immunodeficiency virus infection on drug resistant tuberculosis. Am J Respir Crit Care 154 (1996) 1478-1483
16. Kenyon T.A., Mwasekaga M.J., and Huebner R. Rumisha D, Binkin N, Maganu E. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana. Int J Tuberc Lung Dis 3 (1999) 4-11
17. Dupon M., Texier-Maugein J., and Leroy V. Sentilhes A, Pellegrin JL, Morlat P, et al. Tuberculosis and HIV infection a cohort study of incidence and susceptibility to antituberculosis drugs, Bordeaux, 1985-1993. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. AIDS 9 (1995) 577-583
18. Frieden T.R., Sterling T., and Pablos-Mendez A. Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 328 (1993) 521-526
19. Frieden T.R., Fujiwara P.I., Washko R.M., and Hamburg M.A. Tuberculosis in New York City: turning the tide. N Engl J Med 333 (1995) 229-233
20. Fujiwara P.I., Cook S.V., and Rutherford C.M. Crawford JT, Glickman SE, Kreiswirth BN, et al. A continuing survey of drug-resistant tuberculosis, New York City, April 1994. Arch Int Med 157 (1997) 531-536
21. Agerton T., Valway S., and Gore B. Pozsik C, Plikaytis B, Woodley C, et al. Transmission of a highly drug resistant strain (strain W1) of Mycobacterium tuberculosis. Community outbreak and nosocomial transmission via a contaminated bronchoscope. JAMA 278 (1997) 1073-1077
22. Conover C., Ridzon R., and Valway S. Schoenstadt L, McAuley J, Onorato I, et al. Outbreak of multidrug-resistant tuberculosis at a methadone-treatment program. Int J Tuberc Lung Dis 5 (2001) 59-64
23. Nivin B., Nicholas P., and Gayer M. Frieden TR, Fujiwara PI. A continuing outbreak of multidrug-resistant tuberculosis with nosocomial transmission in a hospital nursery. Clin Infect Dis 26 (1998) 303-307
24. Ridzon R., Kent J.H., and Valway S. Weismuller P, Maxwell R, Elcock M, et al. Outbreak of drug-resistant tuberculosis with a second-generation transmission in a high school in California. J Pediatr 131 (1997) 863-868
25. Sreevastan S., Pan X., and Stockbauer K.E. Connell ND, Kreiswirth BN, Whittam TS, et al. Restricted structural gene polymorphism in the M. tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci USA 94 (1997) 9869-9874
26. van Embden J.D.A., Cave M.D., and Crawford J.T. Dale JW, Eisenach KD, Gicquel B, et al. Strain identification of M. tuberculosis by DNA fingerprinting: recommendations for a standard methodology. J Clin Microbiol 31 (1993) 406-409
27. Kamerbeek J., Schouls L., and Kolk A. van Agterveld M, van Soolingen D, Kuijper S, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 35 (1997) 907-914
28. Pablos-Mendez A., Raviglione M.C., and Laszlo A. Binkin N, Rieder HL, Bustreo F, et al. Global surveillance of antituberculosis-drug resistance, 1994-1997. N Engl J Med 338 (1998) 1641-1649
29. Agerton T.B., Valway S.E., and Blinkhorn R.J. Shilkret KL, Reves R, Schluter WW, et al. Spread of a strain W, a highly drug resistant strain of Mycobacterium tuberculosis, across the United States. Clin Infect Dis 29 (1999) 85-92
30. Moss A.R., Alland D., and Telzak E. Hewlett D Jr, Sharp V, Chiliade P, et al. A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York. Int J Tuberc Lung Dis 1 (1997) 115-121
31. Weis S.E., Slocum P.C., and Blais F.X. King B, Nunn M, Matney GB, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 330 (1994) 1179-1184
32. Munsiff S.S., Bassof T., and Nivin B. Li J, Sharma A, Bifani P, et al. Molecular epidemiology of multidrug-resistant tuberculosis, New York City, 1995-1997. Emerg Infect Dis 8 (2002) 1230-1238
33. Yaganehdoost A., Graviss E.A., and Ross M.W. Adams GJ, Ramaswamy S, Wanger A, et al. Complex transmission dynamics of clonally related virulent Mycobacterium tuberculosis associated with barhopping by predominantly human immunodeficiency virus-positive gay men. J Infect Dis 180 (1999) 1245-1251
34. El Sahly H.M., Wright JA., and Soini H. Bui TT, Williams-Bouyer N, Escalante P, et al. Recurrent tuberculosis in Houston, Texas: a population-based study. Int J Tuberc Lung Dis 8 (2004) 333-340
35. Antoniskis D., Amin K., and Barnes P.F. Pleuritis as a manifestation of reactivation tuberculosis. Am J Med 89 (1990) 447-450
36. Elliot A.M., Berning S.E., Iseman M.D., and Peloquin C.A. Failure of drug penetration and acquisition of drug resistance in chronic tuberculous empyema. Tuberc Lung Dis 76 (1995) 463-467
37. Dutt A.K., Moers D., and Stead W.W. Tuberculous pleural effusion: 6-month-therapy with isoniazid and rifampin. Am Rev Respir Dis 145 (1992) 1429-1432
38. Bamn G., and Malmborg A.S. Rifampicin in plasma and pleural fluid after single oral doses. Eur J Clin Pharmacol 7 (1974) 51-58
39. The Centers for Disease Control and Prevention. Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculsosis with intermittent rifamycin-based regimens. Morb Mortal Wkly Rep 51 (2002) 214-215